NLS Pharmaceutics Ltd

NCEL NASDAQ Santé & Biotech Europe
3.27 $
0.43 %

Société pharmaceutique développant des traitements innovants pour des pathologies liées au sommeil et autres troubles neurologiques, combinant médicaments et médicinales.

Performance & Momentum

6 Months 12.23 %
1 Year 86.33 %
3 Years 99.11 %
5 Years 99.76 %

Similar stocks to NLS Pharmaceutics Ltd

Anantys Community

Be the first to share your analysis on NLS Pharmaceutics Ltd.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases